288 related articles for article (PubMed ID: 37458436)
1. Lysyl oxidase like-2 in fibrosis and cardiovascular disease.
Poe A; Martinez Yus M; Wang H; Santhanam L
Am J Physiol Cell Physiol; 2023 Sep; 325(3):C694-C707. PubMed ID: 37458436
[TBL] [Abstract][Full Text] [Related]
2. LOXL4, but not LOXL2, is the critical determinant of pathological collagen cross-linking and fibrosis in the lung.
Ma HY; Li Q; Wong WR; N'Diaye EN; Caplazi P; Bender H; Huang Z; Arlantico A; Jeet S; Wong A; Emson C; Brightbill H; Tam L; Newman R; Roose-Girma M; Sandoval W; Ding N
Sci Adv; 2023 May; 9(21):eadf0133. PubMed ID: 37235663
[TBL] [Abstract][Full Text] [Related]
3. Abnormal deposition of collagen around hepatocytes in Wilson's disease is associated with hepatocyte specific expression of lysyl oxidase and lysyl oxidase like protein-2.
Vadasz Z; Kessler O; Akiri G; Gengrinovitch S; Kagan HM; Baruch Y; Izhak OB; Neufeld G
J Hepatol; 2005 Sep; 43(3):499-507. PubMed ID: 16023247
[TBL] [Abstract][Full Text] [Related]
4. Extracellular Processing of Lysyl Oxidase-like 2 and Its Effect on Amine Oxidase Activity.
Okada K; Moon HJ; Finney J; Meier A; Mure M
Biochemistry; 2018 Dec; 57(51):6973-6983. PubMed ID: 30499665
[TBL] [Abstract][Full Text] [Related]
5. Lysyl Oxidase (LOX) Family Members: Rationale and Their Potential as Therapeutic Targets for Liver Fibrosis.
Chen W; Yang A; Jia J; Popov YV; Schuppan D; You H
Hepatology; 2020 Aug; 72(2):729-741. PubMed ID: 32176358
[TBL] [Abstract][Full Text] [Related]
6. Lysyl oxidase-like 2 depletion is protective in age-associated vascular stiffening.
Steppan J; Wang H; Bergman Y; Rauer MJ; Tan S; Jandu S; Nandakumar K; Barreto-Ortiz S; Cole RN; Boronina TN; Zhu W; Halushka MK; An SS; Berkowitz DE; Santhanam L
Am J Physiol Heart Circ Physiol; 2019 Jul; 317(1):H49-H59. PubMed ID: 31002285
[TBL] [Abstract][Full Text] [Related]
7. Lysyl oxidase-like 2 processing by factor Xa modulates its activity and substrate preference.
Wang H; Poe A; Martinez Yus M; Pak L; Nandakumar K; Santhanam L
Commun Biol; 2023 Apr; 6(1):375. PubMed ID: 37029269
[TBL] [Abstract][Full Text] [Related]
8. Lysyl Oxidase Family Enzymes and Their Role in Tumor Progression.
Liburkin-Dan T; Toledano S; Neufeld G
Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35682926
[TBL] [Abstract][Full Text] [Related]
9. The lysyl oxidase like 2/3 enzymatic inhibitor, PXS-5153A, reduces crosslinks and ameliorates fibrosis.
Schilter H; Findlay AD; Perryman L; Yow TT; Moses J; Zahoor A; Turner CI; Deodhar M; Foot JS; Zhou W; Greco A; Joshi A; Rayner B; Townsend S; Buson A; Jarolimek W
J Cell Mol Med; 2019 Mar; 23(3):1759-1770. PubMed ID: 30536539
[TBL] [Abstract][Full Text] [Related]
10. Mass Spectrometry-Based Disulfide Mapping of Lysyl Oxidase-like 2.
Meier AA; Go EP; Moon HJ; Desaire H; Mure M
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682561
[TBL] [Abstract][Full Text] [Related]
11. Pan-Lysyl Oxidase Inhibitor PXS-5505 Ameliorates Multiple-Organ Fibrosis by Inhibiting Collagen Crosslinks in Rodent Models of Systemic Sclerosis.
Yao Y; Findlay A; Stolp J; Rayner B; Ask K; Jarolimek W
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628342
[TBL] [Abstract][Full Text] [Related]
12. Lysyl oxidases regulate fibrillar collagen remodelling in idiopathic pulmonary fibrosis.
Tjin G; White ES; Faiz A; Sicard D; Tschumperlin DJ; Mahar A; Kable EPW; Burgess JK
Dis Model Mech; 2017 Nov; 10(11):1301-1312. PubMed ID: 29125826
[TBL] [Abstract][Full Text] [Related]
13. LOXL2 Inhibition Paves the Way for Macrophage-Mediated Collagen Degradation in Liver Fibrosis.
Klepfish M; Gross T; Vugman M; Afratis NA; Havusha-Laufer S; Brazowski E; Solomonov I; Varol C; Sagi I
Front Immunol; 2020; 11():480. PubMed ID: 32296422
[TBL] [Abstract][Full Text] [Related]
14. Anabolic role of lysyl oxidase like-2 in cartilage of knee and temporomandibular joints with osteoarthritis.
Alshenibr W; Tashkandi MM; Alsaqer SF; Alkheriji Y; Wise A; Fulzele S; Mehra P; Goldring MB; Gerstenfeld LC; Bais MV
Arthritis Res Ther; 2017 Aug; 19(1):179. PubMed ID: 28764769
[TBL] [Abstract][Full Text] [Related]
15. Selective targeting of lysyl oxidase-like 2 (LOXL2) suppresses hepatic fibrosis progression and accelerates its reversal.
Ikenaga N; Peng ZW; Vaid KA; Liu SB; Yoshida S; Sverdlov DY; Mikels-Vigdal A; Smith V; Schuppan D; Popov YV
Gut; 2017 Sep; 66(9):1697-1708. PubMed ID: 28073888
[TBL] [Abstract][Full Text] [Related]
16. Lysyl oxidase like-2 contributes to renal fibrosis in Col4α3/Alport mice.
Cosgrove D; Dufek B; Meehan DT; Delimont D; Hartnett M; Samuelson G; Gratton MA; Phillips G; MacKenna DA; Bain G
Kidney Int; 2018 Aug; 94(2):303-314. PubMed ID: 29759420
[TBL] [Abstract][Full Text] [Related]
17. Perturbations to lysyl oxidase expression broadly influence the transcriptome of lung fibroblasts.
Mižíková I; Palumbo F; Tábi T; Herold S; Vadász I; Mayer K; Seeger W; Morty RE
Physiol Genomics; 2017 Aug; 49(8):416-429. PubMed ID: 28698228
[TBL] [Abstract][Full Text] [Related]
18. Dysregulation of extracellular matrix and Lysyl Oxidase in Ehlers-Danlos syndrome type IV skin fibroblasts.
Foehr R; Anderson K; Dombrowski O; Foehr A; Foehr ED
Orphanet J Rare Dis; 2024 Jan; 19(1):9. PubMed ID: 38183136
[TBL] [Abstract][Full Text] [Related]
19. Increased serum lysyl oxidase-like 2 levels correlate with the degree of left atrial fibrosis in patients with atrial fibrillation.
Zhao Y; Tang K; Tianbao X; Wang J; Yang J; Li D
Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29089463
[TBL] [Abstract][Full Text] [Related]
20. Identification and Optimization of Mechanism-Based Fluoroallylamine Inhibitors of Lysyl Oxidase-like 2/3.
Findlay AD; Foot JS; Buson A; Deodhar M; Jarnicki AG; Hansbro PM; Liu G; Schilter H; Turner CI; Zhou W; Jarolimek W
J Med Chem; 2019 Nov; 62(21):9874-9889. PubMed ID: 31580073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
